Beth N Peshkin

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. ncbi request reprint Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing
    Beth N Peshkin
    Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 11:1115-8. 2002
  2. pmc On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children
    Beth N Peshkin
    Jess and Mildred Fisher Center for Familial Cancer Research, Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007 2401, USA
    Fam Cancer 9:89-97. 2010
  3. ncbi request reprint Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians
    Beth N Peshkin
    CGC, 2233 Wisconsin Ave, NW, Suite 317, Washington, DC 20007, USA
    J Clin Oncol 21:4322-8. 2003
  4. pmc BRCA1/2 mutations and triple negative breast cancers
    Beth N Peshkin
    Fisher Center for Familial Cancer Research, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20007 2401, USA
    Breast Dis 32:25-33. 2010
  5. doi request reprint Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial
    Beth N Peshkin
    Lombardi Comprehensive Cancer Center, Jess and Mildred Fisher Center for Familial Cancer Research Georgetown University, Washington, District of Columbia 20007 2401, USA
    Genet Test 12:37-52. 2008
  6. pmc BRCA1/2 test results impact risk management attitudes, intentions, and uptake
    Suzanne C O'Neill
    Cancer Control Program and Fisher Center for Familial Cancer Research, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Breast Cancer Res Treat 124:755-64. 2010
  7. pmc Primary care providers' willingness to recommend BRCA1/2 testing to adolescents
    Suzanne C O'Neill
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven St, NW, Suite 4100, Washington, DC 20007, USA
    Fam Cancer 9:43-50. 2010
  8. pmc Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction
    Marc D Schwartz
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Health Psychol 28:11-9. 2009
  9. pmc Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together
    Tiffani A Demarco
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, USA
    Patient Educ Couns 78:29-33. 2010
  10. pmc Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children
    Kenneth P Tercyak
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007 2401, USA
    Genet Test 11:249-55. 2007

Research Grants

Detail Information

Publications59

  1. ncbi request reprint Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing
    Beth N Peshkin
    Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 11:1115-8. 2002
    ..Noncarriers had very good adherence to general population screening guidelines...
  2. pmc On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children
    Beth N Peshkin
    Jess and Mildred Fisher Center for Familial Cancer Research, Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007 2401, USA
    Fam Cancer 9:89-97. 2010
    ....
  3. ncbi request reprint Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians
    Beth N Peshkin
    CGC, 2233 Wisconsin Ave, NW, Suite 317, Washington, DC 20007, USA
    J Clin Oncol 21:4322-8. 2003
    ..To assess physician recommendations about the use of tamoxifen in premenopausal BRCA1 and BRCA2 mutation carriers...
  4. pmc BRCA1/2 mutations and triple negative breast cancers
    Beth N Peshkin
    Fisher Center for Familial Cancer Research, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20007 2401, USA
    Breast Dis 32:25-33. 2010
    ..Identifying women at increased risk is critical as knowledge of mutation status may impact surgical and systemic treatment in newly diagnosed patients, as well as recommendations for ovarian cancer risk management...
  5. doi request reprint Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial
    Beth N Peshkin
    Lombardi Comprehensive Cancer Center, Jess and Mildred Fisher Center for Familial Cancer Research Georgetown University, Washington, District of Columbia 20007 2401, USA
    Genet Test 12:37-52. 2008
    ..In addition, procedural aspects of the genetic counseling intervention and the novel tools developed to facilitate this process and to ensure adequate counselor training and quality assurance are described...
  6. pmc BRCA1/2 test results impact risk management attitudes, intentions, and uptake
    Suzanne C O'Neill
    Cancer Control Program and Fisher Center for Familial Cancer Research, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Breast Cancer Res Treat 124:755-64. 2010
    ..001). Receipt of BRCA1/2 mutation test results impacts how carriers see the positive aspects of RRO and RRM and their surgical intentions. Both the positive and negative aspects predict uptake of surgery...
  7. pmc Primary care providers' willingness to recommend BRCA1/2 testing to adolescents
    Suzanne C O'Neill
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven St, NW, Suite 4100, Washington, DC 20007, USA
    Fam Cancer 9:43-50. 2010
    ....
  8. pmc Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction
    Marc D Schwartz
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Health Psychol 28:11-9. 2009
    ..To help BRCA1/2 carriers make this decision, the authors developed a computer-based interactive decision aid that was tested against usual care in a randomized controlled trial...
  9. pmc Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together
    Tiffani A Demarco
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, USA
    Patient Educ Couns 78:29-33. 2010
    ....
  10. pmc Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children
    Kenneth P Tercyak
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007 2401, USA
    Genet Test 11:249-55. 2007
    ..In conjunction with enhanced genetic counseling focusing on family disclosure, educational literature, and psychosocial support may promote improved outcomes...
  11. pmc Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children
    McKane E Sharff
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA
    Genet Test Mol Biomarkers 16:376-82. 2012
    ..Among mothers undergoing BRCA1/2 testing and their spouses/partners, this study sought to examine decision support needs and motivations for family communication of genetic risk information to asymptomatic children...
  12. pmc Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS)
    Beth N Peshkin
    Lombardi Comprehensive Cancer Center, USA
    J Pediatr Psychol 34:627-38. 2009
    ..The aim of this study was to develop and evaluate a new measure for use in genetic research and consultation, known as the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS)...
  13. pmc Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance
    Marc D Schwartz
    Department of Oncology, Cancer Control Program, Jess and Mildred Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Cancer 118:510-7. 2012
    ..We evaluated long-term uptake and predictors of risk-reducing mastectomy (RRM), risk-reducing bilateral salpingo-oophorectomy (RRBSO), chemoprevention, and cancer screening among women at a mean of 5.3 years after testing...
  14. ncbi request reprint Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations
    Chanita Hughes Halbert
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, USA
    Cancer Epidemiol Biomarkers Prev 13:875-81. 2004
    ....
  15. ncbi request reprint Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients
    Marc D Schwartz
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    J Clin Oncol 22:1823-9. 2004
    ..In the present study, we prospectively evaluated the impact on surgical decision-making of pretreatment genetic counseling and BRCA1/BRCA2 testing among breast cancer patients at high-risk for carrying a mutation...
  16. ncbi request reprint Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing
    Marc D Schwartz
    Department of Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20007, USA
    J Clin Oncol 21:4034-41. 2003
    ..In this study, we prospectively examined the impact of BRCA1/2 testing on the utilization of prophylactic oophorectomy and ovarian cancer screening. Participants and..
  17. ncbi request reprint Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing
    Kenneth P Tercyak
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007 2401, USA
    J Clin Oncol 25:285-91. 2007
    ..In this study, we compared the impact of BRCA1/2 genetic test result and CPM on these outcomes among newly diagnosed breast cancer patients who opted for CPM at the time of their definitive surgical treatment versus patients who did not...
  18. pmc Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial
    Gillian W Hooker
    Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA
    Med Decis Making 31:412-21. 2011
    ..Individuals who are found to be carriers of a BRCA1 or BRCA2 mutation have a substantially elevated risk for breast cancer and are frequently faced with the decision of whether to undergo risk-reducing mastectomy...
  19. ncbi request reprint Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients
    Marc D Schwartz
    Department of Oncology, Lombardi Comprehensive Cancer Center, Cancer Control Program, Georgetown University School of Medicine, Suite 317, 2233 Wisconsin Avenue, Northwest, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 14:1003-7. 2005
    ..In this study, we evaluated factors associated with the decision to undergo BRCA1/BRCA2 gene testing at the time of initial breast cancer diagnosis...
  20. pmc Intentions for bilateral mastectomy among newly diagnosed breast cancer patients
    Lesley King
    Department of Oncology, Jess and Mildred Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia 20007, USA
    J Surg Oncol 107:772-6. 2013
    ..Few studies have investigated the factors associated with the decision to have more aggressive surgery among young, high risk patients...
  21. ncbi request reprint Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample
    Marc D Schwartz
    Department of Oncology, Georgetown University, and Lombardi Cancer Center, Washington, DC 20007, USA
    J Clin Oncol 20:514-20. 2002
    ..The objective of this study was to examine the long-term psychologic impact of receiving BRCA1/2 test results within a clinic-based testing program...
  22. pmc Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors
    Kristi D Graves
    Cancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA
    Breast Cancer Res Treat 104:321-9. 2007
    ..To reduce the risk of contralateral breast cancer, some patients opt for prophylactic surgery of the unaffected breast (contralateral prophylactic mastectomy, CPM) in addition to mastectomy of the affected breast...
  23. pmc Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer
    Marc D Schwartz
    Marc D Schwartz, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusum, An Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, George Luta, Sarah Kelleher, Kara Grace Leventhal, Patti Vegella, Angie Tong, and Lesley King, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC Heiddis B Valdimarsdottir, Mount Sinai School of Medicine, New York, NY Marie Wood and Wendy McKinnon, Familial Cancer Program of the Vermont Cancer Center, University of Vermont College of Medicine, Burlington, VT Judy Garber and Shelley McCormick, Dana Farber Cancer Institute Harvard Medical School, Boston, MA and Anita Y Kinney, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, UT
    J Clin Oncol 32:618-26. 2014
    ..As genomic testing becomes more common, evaluating alternative delivery approaches becomes increasingly salient. We tested whether telephone delivery of BRCA1/2 genetic counseling was noninferior to in-person delivery...
  24. pmc Conveying genomic recurrence risk estimates to patients with early-stage breast cancer: oncologist perspectives
    Elizabeth Spellman
    Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA
    Psychooncology 22:2110-6. 2013
    ..This study sought to examine medical and surgical oncologists' perceptions of factors related to the translation and integration of Oncotype DX® (Genomic Health, Inc., Redwood City, CA, USA) into routine clinical care...
  25. ncbi request reprint Decision making and decision support for hereditary breast-ovarian cancer susceptibility
    Marc D Schwartz
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA
    Health Psychol 24:S78-84. 2005
    ..In particular, the authors discuss the role of anxiety and worry in relation to testing and surgery decisions...
  26. pmc Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers
    Kristi D Graves
    Department of Oncology and The Fisher Centerfor Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, Northwest, Suite 4100, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 19:648-54. 2010
    ..We examined the effect of the intervention on distress and the concerns related to genetic testing...
  27. pmc Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children
    Kenneth P Tercyak
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 22:1260-6. 2013
    ..Although BRCA1/2 genetic testing is discouraged in minors, mothers may disclose their own results to their children. Factors affecting patients' disclosure decisions and patient outcomes of disclosure are largely unknown...
  28. pmc Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women
    Darren Mays
    Division of Health Outcomes and Health Behaviors, Department of Oncology, Lombardi Comprehensive Cancer, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    Fam Cancer 11:493-502. 2012
    ..More intensive patient navigation addressing the unique barriers encountered within this population may be required to enhance utilization...
  29. pmc Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice
    Kristi D Graves
    Department of Oncology, Cancer Control Program, Breast Cancer Program, Jess and Mildred Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Washington, District of Columbia 20007, USA
    Cancer Epidemiol Biomarkers Prev 21:445-55. 2012
    ..We conducted the first long-term prospective study of psychosocial outcomes in a U.S. sample of women who had BRCA1/2 testing...
  30. ncbi request reprint Can a computer-based system be used to educate women on genetic testing for breast cancer susceptibility?
    Marc D Schwartz
    Georgetown University School of Medicine, and Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA
    Nat Clin Pract Oncol 2:24-5. 2005
  31. ncbi request reprint Predictors of enrollment into a familial cancer registry by individuals at high risk for BRCA1/2
    Kristi D Graves
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, Northwest, Suite 4100, Washington, DC 20007, USA
    Cancer Epidemiol Biomarkers Prev 16:2763-7. 2007
    ..We also sought to identify the factors associated with provision of a blood sample to the FCR...
  32. pmc Adolescent medical providers' willingness to recommend genetic susceptibility testing for nicotine addiction and lung cancer risk to adolescents
    Suzanne C O'Neill
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA
    J Pediatr Psychol 34:617-26. 2009
    ..To examine the influences of disease, lifestyle, and other factors on adolescent medical providers' willingness to recommend genetic susceptibility testing (GST)...
  33. pmc Behavioral and psychosocial responses to genomic testing for colorectal cancer risk
    Kristi D Graves
    Cancer Prevention and Control Program and the Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    Genomics 102:123-30. 2013
    ..Future work can compare risk education with and without SNP results to evaluate if SNP information adds value to existing approaches. ..
  34. pmc Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects
    Kenneth P Tercyak
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA
    Am J Med Genet A 131:36-41. 2004
    ..The implications for future research and clinical practice are discussed...
  35. ncbi request reprint Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer
    Claudine Isaacs
    Department of Medical Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC 20007 2197, USA
    Breast Cancer Res Treat 71:103-12. 2002
    ..These findings indicate a need for better education about screening guidelines for high-risk women...
  36. ncbi request reprint Evaluation and management of women with BRCA1/2 mutations
    Beth N Peshkin
    Oncology and Medicine Department of Cancer Control, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA
    Oncology (Williston Park) 19:1451-9; discussion 1459-68 1474. 2005
    ..We conclude with a review and appraisal of the various options for breast and ovarian cancer risk reduction and screening options for women with a BRCA1 or BRCA2 mutation...
  37. ncbi request reprint Practical aspects of delivering hereditary cancer risk counseling
    Tiffani A Demarco
    Jess and Mildred Fisher Center for Familial Cancer Research, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC 20007, USA
    Semin Oncol 34:369-78. 2007
    ....
  38. pmc Patterns and correlates of multiple risk factors for adult-onset cancer among adolescents(1)
    Darren Mays
    Division of Health Outcomes and Health Behaviors, Department of Oncology, Georgetown University Medical Center, Washington, DC 20007, USA
    J Child Health Care 16:250-62. 2012
    ..05) associated with MCRFs. Multiple health behavior change interventions are needed to prevent accumulation of risk factors as youth mature. Self-efficacy may be an important target for prevention interventions...
  39. pmc Correlates of adherence to a telephone-based multiple health behavior change cancer preventive intervention for teens: the Healthy for Life Program (HELP)
    Darren Mays
    Lombardi Comprehensive Cancer Center, Washington, DC, USA
    Health Educ Behav 39:18-26. 2012
    ..After adjusting for age, teens with poorer session engagement (e.g., less cooperative) completed fewer sessions (B = -1.97, p = .003, R (2) = .24). Implications for adolescent cancer prevention research are discussed...
  40. pmc Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children
    Tiffani A Demarco
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, Washington, DC 20007, USA
    J Genet Couns 17:283-7. 2008
    ..Finally, this report addresses potential ways in which the genetic counselor may be able to facilitate parental communication regarding the evolving process of disclosure of genetic information to children and adolescents...
  41. ncbi request reprint Parent-child factors and their effect on communicating BRCA1/2 test results to children
    Kenneth P Tercyak
    Lombardi Cancer Center, Georgetown University Medical Center, 2233 Wisconsin Avenue, NW, Suite 317, Washington, DC 20007, USA
    Patient Educ Couns 47:145-53. 2002
    ....
  42. ncbi request reprint Discussing race-related limitations of genomic testing for colon cancer risk: Implications for education and counseling
    Morgan N Butrick
    Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    Soc Sci Med 114:26-37. 2014
    ..Clinicians may be better able to engage patients in the use of new genomic technology by increasing their awareness of specific communication processes and patterns during education or counseling sessions. ..
  43. pmc Interest in genetic counseling and testing for adolescent nicotine addiction susceptibility among a sample of adolescent medicine providers attending a scientific conference on adolescent health
    Kenneth P Tercyak
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA
    J Adolesc Health 41:42-50. 2007
    ....
  44. pmc BRCA1/2 genetic testing uptake and psychosocial outcomes in men
    Kristi D Graves
    Cancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA
    Fam Cancer 10:213-23. 2011
    ....
  45. ncbi request reprint Interest of adolescents in genetic testing for nicotine addiction susceptibility
    Kenneth P Tercyak
    Cancer Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007 2401, USA
    Prev Med 42:60-5. 2006
    ..This paper examines adolescents' interest in, and reasons behind interest in, such testing and correlates of interest...
  46. pmc Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS
    Nadiyah Sulayman
    Department of Oncology, The Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    J Cancer Epidemiol 2012:728290. 2012
    ..These data should be confirmed in prospective samples, as these poorer outcomes could be amenable to intervention...
  47. pmc Providers' perceptions and practices regarding BRCA1/2 genetic counseling and testing in African American women
    Kristi D Graves
    Lombardi Comprehensive Cancer Center, Cancer Control Program, Fisher Center for Familial Cancer Research, Georgetown University, Washington, DC 20007, USA
    J Genet Couns 20:674-89. 2011
    ..Results have implications for physician and patient education regarding appropriate referrals to and uptake of genetic services in at-risk African American women...
  48. pmc "Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer
    Kara Grace Leventhal
    Fisher Center for Familial Cancer Research, Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC 20007, USA
    J Genet Couns 22:138-51. 2013
    ..These findings suggest that patients may look to genetic counselors, physicians or other healthcare professionals as gatekeepers of predictive genomic risk information...
  49. ncbi request reprint Genetic discrimination in health insurance: current legal protections and industry practices
    Karen Pollitz
    Georgetown University Health Policy Institute, Washington, DC 20057, USA
    Inquiry 44:350-68. 2007
    ..In seven of these 92 applications, underwriters said they would deny coverage, place a surcharge on premiums,or limit covered benefits based on an applicant's genetic information...
  50. ncbi request reprint Oophorectomy in carriers of BRCA mutations
    Beth N Peshkin
    N Engl J Med 347:1037-40; author reply 1037-40. 2002
  51. ncbi request reprint Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results
    Suzanne C O'Neill
    Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Am J Med Genet C Semin Med Genet 142:251-9. 2006
    ..The clinical and research implications of these results are discussed...
  52. ncbi request reprint Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?
    Beth N Peshkin
    J Clin Oncol 25:911-2; author reply 913. 2007
  53. pmc Validity of models for predicting BRCA1 and BRCA2 mutations
    Giovanni Parmigiani
    The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 2011, USA
    Ann Intern Med 147:441-50. 2007
    ..At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood...
  54. ncbi request reprint All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results
    Chanita Hughes
    Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Am J Med Genet 107:143-50. 2002
    ....
  55. ncbi request reprint BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes
    Donald A Berry
    Department of Biostatistics, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 20:2701-12. 2002
    ....
  56. ncbi request reprint A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire
    David Cella
    Center on Outcomes Research and Education, Evanston Northwestern Healthcare, Illinois 60201, USA
    Health Psychol 21:564-72. 2002
    ..77), and Positive Experiences (4 items, alpha = .75). All 3 MICRA subscales differentiated participants who were BRCA1/2 positive from the other 3 groups. MICRA thus helps identify subgroups of vulnerable genetic testing participants...
  57. ncbi request reprint Breast cancer risk assessment and genetic testing: complexities, conundrums, and community
    Beth N Peshkin
    Breast Dis 27:1-3. 2006
  58. ncbi request reprint Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations
    Chanita Hughes Halbert
    Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Behav Med 27:373-92. 2004
    ..001). These results suggest that interventions designed to address perceptions of stress related to medical decision-making and familial concerns may need to be targeted to BRCA1/2 mutation carriers and individuals who are highly anxious...
  59. pmc Characterization of BRCA1 and BRCA2 mutations in a large United States sample
    Sining Chen
    Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
    J Clin Oncol 24:863-71. 2006
    ..Existing studies have focused on Ashkenazi Jews (AJ) or on families from outside the United States. In this article, we consider the US population using the largest US-based cohort to date of both AJ and non-AJ families...

Research Grants1

  1. BRCA1/2 Education for Mothers and Their Teen Daughters
    BETH PESHKIN; Fiscal Year: 2006
    ..It is expected that with respect to issues surrounding hereditary cancer susceptibility, the resource will result in improved knowledge, communication, and support among mothers and their teenage daughters. ..